$ Value
$0
Shares
1,835
Price
$0
Filed
Nov 4
Insider
Name
Scimeca Dario
Title
General Counsel and Secretary
CIK
0001779581
Roles
Transaction Details
Transaction Date
2025-11-02
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2025. | Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. | Includes 2,088 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $4.26. | The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. | On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025.
Filing Info
Scimeca Dario's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-18 | DTIL | ▼ | $19K |
| 2026-02-17 | DTIL | M | $0 |
| 2026-02-17 | DTIL | M | $0 |
| 2026-01-21 | DTIL | ▼ | $36K |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
| 2026-01-20 | DTIL | M | $0 |
Other Insiders at DTIL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Kelly John Alexander
Chief Financial Officer
|
— | $31K | 2026-02-18 |
|
SMITH J. JEFFERSON
Chief Research Officer
|
— | $19K | 2026-02-18 |
|
Scimeca Dario
General Counsel and Secretary
|
— | $19K | 2026-02-18 |
|
Amoroso Michael
President and CEO
|
— | $79K | 2026-02-18 |